Cargando…
Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome
OBJECTIVE: We sought to evaluate the effect of antiplatelet therapy in addition to conventional immunosuppressive therapy for lupus nephritis (LN) patients positive for antiphospholipid antibodies (aPL) without definite antiphospholipid syndrome (APS). METHODS: Patients with biopsy-proven LN class I...
Autores principales: | Hanaoka, Hironari, Iida, Harunobu, Kiyokawa, Tomofumi, Takakuwa, Yukiko, Okazaki, Takahiro, Yamada, Hidehiro, Ozaki, Shoichi, Kawahata, Kimito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933765/ https://www.ncbi.nlm.nih.gov/pubmed/29723256 http://dx.doi.org/10.1371/journal.pone.0196172 |
Ejemplares similares
-
Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV
por: Hanaoka, Hironari, et al.
Publicado: (2018) -
Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus
por: Hanaoka, Hironari, et al.
Publicado: (2019) -
Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study
por: Hanaoka, Hironari, et al.
Publicado: (2017) -
Rhabdomyolysis in a Patient with Polyarteritis Nodosa
por: Iida, Harunobu, et al.
Publicado: (2017) -
Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV
por: Hanaoka, Hironari, et al.
Publicado: (2017)